MNRO

Over the past six months, Monro's stock price declined by 32.40% from $17.90 on September 22, 2025, to $12.10 on September 18, 2026, trading between a 52-week high of $23.91 and a low of $11.06 as of October 9, 2026. Key events include the Q1 Fiscal Year 2027 financial results, announced July 29, 2026, which reported a net loss of $2.1 million, a 4.6% sales decrease to $287.1 million due to store closures and lower traffic, and a 1.7% decline in comparable store sales as consumers deferred higher-ticket spending and traded down in tires, resulting in an Adjusted EPS of -$0.09 that missed analyst estimates. Q4 Fiscal Year 2026 financial results, announced May 27, 2026, showed a 2.4% sales decrease due to store closures and lower comparable store sales, with full-year fiscal 2026 sales decreasing 3.2% to $1.157 billion, primarily driven by the closure of 145 underperforming stores. Monro declared a quarterly cash dividend of $0.28 per share, payable on September 8, 2026, and announced its participation in the Piper Sandler 2026 Growth Frontiers Conference in September 2026. Carl Icahn significantly increased his stake in Monro by 247% to over 5 million shares, despite the company's adoption of a "poison pill" defense. The company is also facing uncertainty from a strategic review and macroeconomic headwinds, including consumer pressure from high gasoline, food, and healthcare costs, which have constrained spending on discretionary automotive services.